ABC transporter gene expression in benign and malignant ovarian tissue

Area of Science:

• Oncology
• Molecular Biology
• Pharmacology

Background:

• ATP-binding Cassette (ABC) transporters are implicated in multidrug resistance (MDR) in carcinomas.
• Existing gene expression data for ABC transporters in ovarian cancer is conflicting and limited.

Purpose of the Study:

• To provide a comprehensive analysis of ABC transporter RNA levels in ovarian cancer.
• To identify key ABC transporters involved in chemoresistance in ovarian carcinoma.

Main Methods:

• Real-time PCR was employed to quantify RNA expression of 9 ABC transporters in benign and recurrent ovarian cancer tissues (n=50 each).
• Significant genes were further analyzed in primary ovarian cancer samples (n=50).
• Statistical analysis included ROC curves and Wilcoxon-Mann-Whitney U-tests with Shaffer correction.

Main Results:

• Gene expression of ABCC1, ABCC2, ABCC3, and ABCB3 was significantly higher in recurrent ovarian cancer compared to benign tissue.
• All four identified transporters showed significant differences between primary and recurrent tumor tissues.
• Expression changes between benign and primary lesions were minimal.

Conclusions:

• Four specific ABC transporters (ABCC1, ABCC2, ABCC3, ABCB3) are likely crucial for MDR in ovarian carcinoma.
• Their gene expression appears to be induced by chemotherapy, supporting the hypothesis that MDR is acquired during treatment.
• These findings suggest MDR in ovarian cancer is therapy-acquired rather than inherent.